1. Home
  2. News
  3. News
  4. Obtained the IND approval from the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare in Taiwan "A randomized, placebo-controlled trial to evaluate the safety, tolerability and potential efficacy of intranasal administration on

Obtained the IND approval from the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare in Taiwan "A randomized, placebo-controlled trial to evaluate the safety, tolerability and potential efficacy of intranasal administration on

Obtained the IND approval from the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare in Taiwan "A randomized, placebo-controlled trial to evaluate the safety, tolerability and potential efficacy of intranasal administration on AD17002 [LTh(αΚ)] aim at subjects with allergic rhinitis caused by house-dust mites. "
2018-11-05
Back
繁體中文
English
简体中文
This site uses cookies to collect the necessary user browsing behavior so that we can provide you with a better browsing experience. Browse this site, which means you agree with "online privacy declaration."